The ACA requires Part D plans to provide an annual comprehensive review of the participating beneficiary’s medications, which may result in the preparation of a medication action plan or other instructions for the beneficiary. CMS has released its draft standardized format for such medication review action plans. In addition, CMS has issued guidance to Part D plan sponsors on the process for CY 2012 medication therapy management program submissions and related change requests. CMS also has issued a memo on CY 2012 formulary submissions, including timelines.